Abstract |
This essay summarizes my 40 years of research in immunology. As a young physician, I encountered a patient with Waldenström's macroglobulinemia, and this inspired me to study the structure of IgM. I began to ask how antibody responses are regulated. In the late 1960s, the essential role of T cells in antibody production had been reported. In search of molecules mediating T cell helper function, I discovered activities in the culture supernatant of T cells that induced proliferation and differentiation of B cells. This led to my life's work: studying one of those factors, interleukin-6 (IL-6). To my surprise, IL-6 turned out to play additional roles, including myeloma growth factor and hepatocyte-stimulating factor activities. More importantly, it was involved in a number of diseases, such as rheumatoid arthritis and Castleman's disease. I feel exceptionally fortunate that my work not only revealed the framework of cytokine signaling, including identification of the IL-6 receptor, gp130, NF-IL6, STAT3, and SOCS-1, but also led to the development of a new therapy for chronic inflammatory diseases.
|
Authors | Tadamitsu Kishimoto |
Journal | Annual review of immunology
(Annu Rev Immunol)
Vol. 23
Pg. 1-21
( 2005)
ISSN: 0732-0582 [Print] United States |
PMID | 15771564
(Publication Type: Biography, Historical Article, Journal Article, Portrait, Review)
|
Chemical References |
- Immunoglobulin M
- Interleukin-6
|
Topics |
- Allergy and Immunology
(history)
- B-Lymphocytes
(immunology)
- History, 20th Century
- History, 21st Century
- Humans
- Immunoglobulin M
(history)
- Interleukin-6
(history)
- Japan
- Signal Transduction
|